Results
4047
Companies which are more than 50% undervalued based on analyst price target.
4,047 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2313 | HK$59.75 | 0.5% | -13.7% | HK$89.8b | HK$89.87 | PE15.6x | E12.2% | 4.1% | Consumer Durables | ||
KCHOL | ₺158.00 | -2.4% | -8.9% | ₺400.7b | ₺286.38 | PE23x | E174.5% | 5.1% | Capital Goods | ||
NICE | ₪620.30 | -0.9% | -24.4% | ₪39.0b | ₪936.35 | PE25.8x | E14.4% | 0% | Software | ||
SMPH | ₱21.85 | -11.2% | -33.9% | ₱631.0b | ₱35.79 | PE14.4x | E7.7% | 1.6% | Real Estate Management and Development | ||
GGAL | AR$6,650.00 | -11.3% | 187.7% | AR$11.3t | AR$10,279.25 | PB2.4x | E7.8% | 0.4% | Banks | ||
PCVX | US$84.00 | -2.3% | 11.6% | US$10.5b | US$149.89 | PB3.1x | E29.3% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$107.95 | -4.2% | -19.8% | US$10.3b | US$181.78 | PE84.6x | E30.1% | n/a | Pharmaceuticals & Biotech | ||
A006400 | ₩219,500.00 | 4.0% | -44.4% | ₩14.6t | ₩355,058.62 | PE6.8x | E-1.6% | 0% | Tech | ||
688506 | CN¥181.22 | 1.5% | 55.8% | CN¥72.7b | CN¥278.91 | PE19.1x | E-96.6% | 0% | Pharmaceuticals & Biotech | ||
PUREHEALTH | د.إ3.21 | -3.0% | -31.6% | د.إ35.7b | د.إ4.95 | PE31.7x | E34.2% | n/a | Healthcare | ||
ADANIENSOL | ₹702.00 | -5.4% | -34.7% | ₹843.3b | ₹1,415.25 | PE108.9x | E52.4% | n/a | Utilities | ||
CEMEX CPO | Mex$13.85 | 1.7% | 2.7% | Mex$196.8b | Mex$32.71 | PE11.1x | E11.1% | 0.3% | Materials | ||
EDPR | €8.64 | -1.7% | -38.6% | €9.0b | €13.35 | PE121.3x | E37.5% | 2.3% | Utilities | ||
SWIGGY | ₹338.25 | -6.6% | n/a | ₹766.0b | ₹544.44 | PS5.5x | E66.4% | n/a | Consumer Services | ||
VFS | US$3.77 | -0.5% | -31.0% | US$8.8b | US$6.33 | PS6x | E1.0% | n/a | Automobiles | ||
FROTO | ₺907.50 | -1.1% | -5.4% | ₺318.5b | ₺1,494.55 | PE9.5x | E29.5% | 6.3% | Automobiles | ||
PSN | US$73.46 | -5.8% | -1.9% | US$7.8b | US$115.31 | PE99.1x | E63.4% | n/a | Commercial Services | ||
NESTE | €9.65 | -18.6% | -64.7% | €7.4b | €15.70 | PS0.4x | E52.7% | 12.4% | Energy | ||
CACI | US$338.51 | -11.4% | -7.6% | US$7.6b | US$520.83 | PE15.8x | E8.1% | n/a | Commercial Services | ||
ROIV | US$10.56 | -2.1% | -8.9% | US$7.5b | US$16.00 | PS61.5x | E18.5% | n/a | Pharmaceuticals & Biotech | ||
RVMD | US$40.67 | -3.3% | 37.8% | US$7.5b | US$73.29 | PS10128.9x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
2883 | HK$6.51 | -4.3% | -4.1% | HK$57.5b | HK$9.94 | PE9.1x | E23.0% | 3.5% | Energy | ||
AES | US$9.93 | -7.6% | -40.8% | US$7.1b | US$15.85 | PE6.9x | E12.5% | 7.1% | Utilities | ||
CPN | ฿51.50 | 0% | -20.5% | ฿231.1b | ฿77.28 | PE13.7x | E6.3% | 3.5% | Real Estate Management and Development |